During the past decade, Barrow Neurological Institute at St.Joseph's Hospital and Medical Center conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 4 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Barrow Neurological Institute at St.Joseph's Hospital and Medical Center" #1 sponsor was "St. Joseph's Hospital and Medical Center, Phoenix" with 15 trials, followed by "Celldex Therapeutics" with 2 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Cytokinetics" with 1 trials sponsored and "Ekso Bionics" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Barrow Neurological Institute at St.Joseph's Hospital and Medical Center" #1 collaborator was "Translational Genomics Research Institute" with 4 trials as a collaborator, "Arizona State University" with 2 trials as a collaborator, "American Society of Clinical Oncology" with 1 trials as a collaborator, "Arizona Commerce Commission, Phoenix AZ" with 1 trials as a collaborator and "Barbara Ann Karmanos Cancer Institute" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Barrow Neurological Institute at St.Joseph's Hospital and Medical Center" are "Glioblastoma" (4 trials), "Glioma" (3 trials), "Multiple Sclerosis, Relapsing-Remitting" (3 trials), "Parkinson Disease" (3 trials) and "Parkinson's Disease" (3 trials). Many other conditions were trialed in "Barrow Neurological Institute at St.Joseph's Hospital and Medical Center" in a lesser frequency.

Most popular intervention types in "Barrow Neurological Institute at St.Joseph's Hospital and Medical Center" are "Drug" (14 trials), "Device" (6 trials), "Other" (5 trials), "Procedure" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Temozolomide" (3 trials), "KLH" (2 trials), "Rindopepimut (CDX-110) with GM-CSF" (2 trials) and ""Low O.R. Traffic"" (1 trials). Other intervention names were less common.

The vast majority of trials in "Barrow Neurological Institute at St.Joseph's Hospital and Medical Center" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Barrow Neurological Institute at St.Joseph's Hospital and Medical Center". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 12 completed trials in Barrow Neurological Institute at St.Joseph's Hospital and Medical Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Barrow Neurological Institute at St.Joseph's Hospital and Medical Center, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".